Current Edition

Cardiovascular Safety Watch Column

Some previous columns in this series have provided reports of the proceedings of cardiac safety conferences. On this occasion, the column by J. Rick Turner of Quintiles provides advance notification of a meeting that may have a considerable impact on proarrhythmic cardiac safety investigations for new drugs. Readers who are able to attend are encouraged to do so.